InvestorsHub Logo

XenaLives

03/05/18 12:47 PM

#143487 RE: rocalinda #143485

Agreed...


Executive Consultant
Biotech Consultant
2015 – 2016 (1 year)
• Implement launch of US expanded access program and global EAPs for a phase III company
• Develop US launch and market access plan for a neurology company
• Run early global pricing analysis for a phase I/II biotech
• Develop fundraising plan for a pre-clinical biotech company
• Built early commercial strategy and access for a phase IIb biotech